News
PharmAust (ASX: PAA) has changed its name to Neurizon Therapeutics - NUZ (ASX: NUZ).
Below are the previous articles from PharmAust (ASX: PAA):
RELATED STOCKHEAD STORIES
Health & Biotech
So, COVID vaccines are here; what now for all those biotechs working on COVID 19 drugs or tests?
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Who else on the ASX joins Mesoblast in the fight against ARDS and where are they at?
Health & Biotech
Check Up: A bit of progress for the health sector
News
Weekly ASX small cap wrap: Who can’t afford to put pork on their fork this week?
Health & Biotech
Cyclopharm, AnteoTech and PharmAust report COVID-19 progress
Health & Biotech
PharmAust gets on the hunt for a new partner to develop its canine cancer treatment
News
10 at 10: These ASX stocks are a landslide this morning
Health & Biotech
SomnoMed taps tech for new board hires, posts full-year profit
Health & Biotech
How many stocks fighting COVID-19 have maintained their momentum?
News
10 at 10: These ASX stocks are casting nets this morning
News
Rise and Shine: What you need to know before the ASX opens
News
10 at 10: These ASX stocks are looking colourful this morning
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Selvax cures cancer in dogs, says it’s eyeing an IPO
News
